Table 2 Responder vs. non-responder based on NYHA change.
Variable | NYHA change | |||
|---|---|---|---|---|
Responder (n = 39) | Non-responder (n = 19) | p-value* | ||
LVEF change [%] | 6.0 ± 6.7 | 1.3 ± 3.1 | < 0.01 | |
TAPSE change [mm] | 1.5 ± 2.3 | 0.3 ± 1.7 | 0.06 | |
MLWHF change | − 19.3 ± 17.4 | -5.6 ± 16.4 | 0.06 | |
NT-pro BNP (pg/mL) change | − 1912 ± 2490 | 1431 ± 5178 | < 0.01 | |
NYHA change, n (%) | − 2 | 9 (23.1%) | – | < 0.01 |
− 1 | 30 (76.9%) | – | ||
0 | – | 17 (89.5%) | ||
+ 1 | – | 2 (10.5%) | ||
Lead stimulation, n (%) | Single | 12 (30.8%) | 6 (31.6%) | 0.95 |
Dual | 27 (69.2%) | 13 (68.4%) | ||
LGE of at least 25% at lead position (both single and dual) | LGE > 25% (Group A) | 4 (10.3%) | 6 (44.4%) | < 0.01 |
LGE < 25% (Group B) | 35 (89.7%) | 10 (55.6%) | ||
